🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Critically ill patients with high risk for thrombosis or tromboembolic even...
Status
Completed
Location
Medical University Innsbruck / Department for General and Surgical Intensive Care Medicine
Start Date
2012-07-29
Trial ID
NCT01734252
Treatments Being Tested
An Open-Label, Randomised, Active Controlled, Multi-Centre Phase 3 Study to...
Status
Terminated
Location
Shands University of Florida
Start Date
2019-05-16
Trial ID
NCT03809481
Treatments Being Tested
The study is designed to characterize the safety and tolerability of VLX-10...
Status
Completed
Location
Celerion, Inc.
Start Date
2022-03-07
Trial ID
NCT05325346
Treatments Being Tested
Unfractionated heparin is most common in the anticoagulation management of ...
Status
Completed
Location
Bing Sun
Start Date
2021-07-06
Trial ID
NCT04925167
Treatments Being Tested
Edaravone, a free radical scavenger, is a novel neuroprotective agent, and ...
Status
Completed
Location
EAST Study Office c/o National Cardiovascular Center
Start Date
2004-08
Trial ID
NCT00153946
Treatments Being Tested
Argatroban is a selective thrombin inhibitor, and previous study had sugges...
Status
Completed
Location
Department of Neurology, Jinling Hospital, Nanjing University School of Medicine
Start Date
2010-08
Trial ID
NCT01163604
Treatments Being Tested
A three-arm randomized controlled non-inferiority pilot study comparing ant...
Status
Recruiting
Location
Medical University of Vienna
Start Date
2024-07-30
Trial ID
NCT06442267
Treatments Being Tested
Safety and efficacy of direct thrombin inhibitors versus enoxaparin in pati...
Status
Completed
Location
KUleuven/UZ Gasthuisberg
Start Date
2013-01
Trial ID
NCT01911624
Treatments Being Tested
The primary goals of this investigation are to provide guidance on how to d...
Status
Completed
Location
University of Chicago, Section of Nephrology
Start Date
2002-05
Trial ID
NCT00035178
Treatments Being Tested
The purpose of this study is to evaluate the safe and effective dose of Arg...
Status
Completed
Location
Mattel Children's Hospital at UCLA
Start Date
2003-09
Trial ID
NCT00039858
Treatments Being Tested